Several in vivo and in vitro studies [23,24] have shown that hypertriglyceridemia diminishes glucose-induced insulin secretion via the glucose–fatty acid cycle in which fatty acid oxidation inhibits glucose oxidation by decreasing pyruvate dehydrogenase (PDH) activity and increasing PDH kinase activity. Here, PDP1 is linked to hypertriglyceridemia.